A Closer Look at Spravato (Esketamine) - What will the drug cost and will insurance cover it?


Manage episode 229190432 series 1756689
著作 Ketamine Wellness Centers の情報はPlayer FM及びコミュニティによって発見されました。著作権は出版社によって所持されます。そして、番組のオーディオは、その出版社のサーバから直接にストリーミングされます。Player FMで購読ボタンをタップし、更新できて、または他のポッドキャストアプリにフィードのURLを貼り付けます。
As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention. This episode focuses on the cost of Spravato to the provide, end user, and insurer: - What are the preliminary cost estimates for Spravato (wholesale) - Can we estimate the cost to the patient? - Will insurance cover the drug? - How will the treatment schedule effect the cost? www.ketaminewellnesscenters.com/category/podcast/

15 つのエピソード